AaronDBosslerMDPhD

PubMed

• 17 citations
  PTCH1-GLI1 Fusion–Positive Ovarian Tumor: Report of a Unique Case With Response to Tyrosine Kinase Inhibitor Pazopanib
  Rofieda R Alwaqfi, Megan I Samuelson, Natalya N Guseva, Michelle Ouyang, Deqin Ma, Aaron D. Bossler> ;Journal of the National Comprehensive Cancer Network. 2021 Sep 20
• Monocytes Exposed to Immune Complexes Reduce pDC Type 1 Interferon Response to Vidutolimod
  Caitlin D Lemke-Miltner, Sue E. Blackwell, Chaobo Yin, Kareem Ebeid, Aliasger K. Salem, George J. Weiner, Aaron D. Bossler, Shakoora A Sabree> ;Vaccines. 2021 Sep 2
• 25 citations
  Validation of Optical Genome Mapping for the Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy
  Aaron A. Stence, Jon G. Thomason, Jonathan A. Pruessner, Ramakrishna Sompallae, Anthony N. Snow, Deqin Ma, Steven A. Moore, Aaron D. Bossler> ;The Journal of Molecular Diagnostics. 2021 Aug 9
• 7 citations
  Melanoma Brain Metastases in the Era of Targeted Therapy and Checkpoint Inhibitor Therapy
  John M. Rieth, Umang Swami, Sarah L. Mott, Mario Zanaty, Michael D. Henry, Jeremy D.W. Greenlee, Yousef Zakharia, Marion Vanneste, Brooke Jennings, Mohammed M. Milhem,...> ;Cancers. 2021 Mar 24
• 2 citations
  CLL dedifferentiation to clonally related myeloid cells.
  Qianze Dong, Yan Xiu, Sergei Syrbu, Hongming Wang, Weishuang Xue, Jinming Zhao, Qingchang Li, Meiling Jin, Lili Wang, Brendan F. Boyce, Hany Sakr, Mohammad Q Ansari, C...> ;Blood Advances. 2020 Dec 22
• 14 citations
  CLIA Laboratory Testing for Facioscapulohumeral Dystrophy (FSHD): A Retrospective Analysis
  Katherine D. Mathews, Steven A. Moore, Aaron D. Bossler, Autumn Rieken> ;Neurology. 2020 Dec 21
• 9 citations
  Multivariable Analysis of 169 Cases of Advanced Cutaneous Melanoma to Evaluate Antibiotic Exposure as Predictor of Survival to Anti-PD-1 Based Immunotherapies.
  Umang Swami, Adithya Chennamadhavuni, Sarah L. Mott, Rohan Garje, Yousef Zakharia, Mohammed M. Milhem, Aaron D. Bossler, Nicholas Borcherding> ;Antibiotics. 2020 Oct 27
• 7 citations
  Exploration of PCORnet Data Resources for Assessing Use of Molecular-Guided Cancer Treatment.
  Ryan M. Carnahan, Lemuel R. Waitman, Mary E. Charlton, Mary C. Schroeder, W. Scott Campbell, James R. Campbell, Bradley D. McDowell, Nicholas Smith, Brian M. Gryzlak, ...> ;JCO Clinical Cancer Informatics. 2020 Aug 14
• 14 citations
  Coactivation of NF-κB and Notch signaling is sufficient to induce B-cell transformation and enables B-myeloid conversion.
  Yan Xiu, Qianze Dong, Lin Fu, Aaron D. Bossler, Xiaobing Tang, Brendan F. Boyce, Nicholas Borcherding, Mariah R. Leidinger, Jose Luis Sardina, Hai-Hui Xue, Qingchang L...> ;Blood. 2020 Jan 9
• 9 citations
  Exceptional responses with sequential metronomic temozolomide after pembrolizumab failure in patients with metastatic melanoma.
  Umang Swami, Varun Monga, Michele Freesmeier, Weizhou Zhang, Yousef Zakharia, Mohammed M. Milhem, Aaron D. Bossler> ;Melanoma Research. 2019 Dec 1
• 15 citations
  Durable Clinical Benefit in Patients with Advanced Cutaneous Melanoma after Discontinuation of Anti-PD-1 Therapies Due to Immune-Related Adverse Events.
  Umang Swami, Varun Monga, Yousef Zakharia, Mohammed M. Milhem, Aaron D. Bossler> ;Journal of Oncology. 2019 Jul 25
• 8 citations
  Urothelial carcinoma with an NRF1-BRAF rearrangement and response to targeted therapy.
  Alexandra L Isaacson, Natalya V. Guseva, Deqin Ma, Aaron D. Bossler> ;Cold Spring Harbor Molecular Case Studies. 2019 Jun 1
• 17 citations
  BCR-NTRK2 fusion in a low-grade glioma with distinctive morphology and unexpected aggressive behavior.
  Karra A. Jones, Andrew M. Bellizzi, Anthony N. Snow, Aaron D. Bossler> ;Cold Spring Harbor Molecular Case Studies. 2019 Apr 1
• 8 citations
  Toxicities with targeted therapies after immunotherapy in metastatic melanoma.
  Nicole Grogan, Umang Swami, Yousef Zakharia, Mohammed M. Milhem, Aaron D. Bossler> ;Melanoma Research. 2018 Dec 1
• 39 citations
  TRAPPC11 and GOSR2 mutations associate with hypoglycosylation of α-dystroglycan and muscular dystrophy
  Austin Larson, Peter R. Baker, Miroslav P. Milev, Craig A. Press, Ronald J. Sokol, Mary O. Cox, Jacqueline K. Lekostaj, Aaron A. Stence, Jennifer Mueller, Keshika Prem...> ;Skeletal Muscle. 2018 May 31
• Correction to: Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy.
  Kim A. Brogden, Deepak Parashar, Andrea R. Hallier, Terry A. Braun, Fang Qian, Naiyer A. Rizvi, Mohammed M. Milhem, Timothy A. Chan, Taher Abbasi, Shireen Vali, Aaron ...> ;BMC Cancer. 2018 Apr 12
• 5 citations
  Biallelic TP53 gain of function mutations in rapidly progressing solid tumors
  Christopher M Sande, Varun Monga, Deqin Ma, Brian Chang, Aaron D. Bossler> ;Cancer Genetics. 2018 Apr 1
• 16 citations
  Simultaneous detection of single‐nucleotide variant, deletion/insertion, and fusion in lung and thyroid carcinoma using cytology specimen and an RNA‐based next‐generat...
  Natalya V. Guseva, Omar I. Jaber, Aaron A. Stence, Krishnaveni Sompallae, Amani Bashir, Ramakrishna Sompallae, Chris S. Jensen, Deqin Ma, Aaron D. Bossler> ;Cancer Cytopathology. 2018 Mar 1
• 22 citations
  Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy
  Kim A. Brogden, Deepak Parashar, Andrea R. Hallier, Terry A. Braun, Fang Qian, Naiyer A. Rizvi, Mohammed M. Milhem, Timothy A. Chan, Taher Abbasi, Shireen Vali, Aaron ...> ;BMC Cancer. 2018 Feb 27
• 15 citations
  A Phase I/II Study Targeting Angiogenesis Using Bevacizumab Combined with Chemotherapy and a Histone Deacetylase Inhibitor (Valproic Acid) in Advanced Sarcomas.
  Varun Monga, Umang Swami, Munir R. Tanas, Sarah L. Mott, Brian J. Smith, Mohammed M. Milhem, Aaron D. Bossler> ;Cancers. 2018 Feb 17
• 27 citations
  Targeting epigenetics for treatment of BRAF mutated metastatic melanoma with decitabine in combination with vemurafenib: A phase lb study
  Yousef Zakharia, Varun Monga, Umang Swami, Michele Freesmeier, Melanie Frees, Mirza Khan, Noah Frydenlund, Rithu Srikantha, Marion Vanneste, Michael D. Henry, Mohammed...> ;Oncotarget. 2017 Sep 26
• 54 citations
  Anchored multiplex PCR for targeted next-generation sequencing reveals recurrent and novel USP6 fusions and upregulation of USP6 expression in aneurysmal bone cyst.
  Natalya V. Guseva, Omar I. Jaber, Munir R. Tanas, Aaron A. Stence, Ramakrishna Sompallae, Jenna C. Schade, Allison N. Fillman, Benjamin J. Miller, Deqin Ma, Aaron D. B...> ;Genes, Chromosomes & Cancer. 2017 Apr 1
• 12 citations
  Melanoma cells undergo aggressive coalescence in a 3D Matrigel model that is repressed by anti-CD44.
  Deborah Wessels, Daniel F. Lusche, Edward Voss, Spencer Kuhl, Emma C. Buchele, Michael R. Klemme, Kanoe B. Russell, Joseph Ambrose, Benjamin A. Soll, Mohammed M. Milhe...> ;Plos One. 2017 Mar 6
• 21 citations
  The NAB2-STAT6 gene fusion in solitary fibrous tumor can be reliably detected by anchored multiplexed PCR for targeted next-generation sequencing.
  Natalya V. Guseva, Munir R. Tanas, Aaron A. Stence, Ramakrishna Sompallae, Jenna C. Schade, Andrew M. Bellizzi, Deqin Ma, Aaron D. Bossler> ;Cancer Genetics. 2016 Jul 1
• 67 citations
  Genomic Sequencing Procedure Microcosting Analysis and Health Economic Cost-Impact Analysis: A Report of the Association for Molecular Pathology
  Linda Sabatini, Charles Mathews, Devon Ptak, Shivang Doshi, Katherine Tynan, Madhuri Hegde, Tara L. Burke, Aaron D. Bossler> ;The Journal of Molecular Diagnostics. 2016 May 1
• Join now to see all